Citation Impact
Citing Papers
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Aerosolized Tobramycin in The Treatment of Ventilator-Associated Pneumonia: A Pilot Study
2007
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
1999 Standout
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review
2010
Functional diversity of helper T lymphocytes
1996 StandoutNature
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Altered immune responses in mice lacking inducible nitric oxide synthase
1995 StandoutNature
CD14 Is a pattern recognition receptor
1994
Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome
1996
Circulating mitochondrial DAMPs cause inflammatory responses to injury
2010 StandoutNature
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
2001 Standout
Comparison of Ampicillin‐Sulbactam and Imipenem‐Cilastatin for the Treatment ofAcinetobacterVentilator‐Associated Pneumonia
2002
Minimal Sulfated Carbohydrates for Recognition by L-selectin and the MECA-79 Antibody
2000 StandoutNobel
Recognition of Gram-negative bacteria and endotoxin by the innate immune system
1999
Digestion of Streptococcus pneumoniae Cell Walls with Its Major Peptidoglycan Hydrolase Releases Branched Stem Peptides Carrying Proinflammatory Activity
1999
β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis
2013
Collagen-Induced Arthritis in Mice: Synergistic Effect of E. Coli Lipopolysaccharide Bypasses Epitope Specificity in the Induction of Arthritis with Monoclonal Antibodies to Type II Collagen
1995
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
2000
Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
1991
Sepsis and the systemic inflammatory response syndrome
1996
Current Understanding of Sepsis
1996
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
2010
Whole Blood Leukocyte Mitogen Activated Protein Kinases Activation Differentiates Intensive Care Unit Patients With Systemic Inflammatory Response Syndrome and Sepsis
2007
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Comparison of Ceftriaxone with Cefotaxime in Serious Chest Infections
1989
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
1994 StandoutNature
Toll-like receptors in the induction of the innate immune response
2000 StandoutNature
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
2001 StandoutNature
Recognition of endotoxin by cells leading to transmembrane signaling
1994
Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic Shock
1995
A 3-Level Prognostic Classification in Septic Shock Based on Cortisol Levels and Cortisol Response to Corticotropin
2000
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*
2007
Has the mortality of septic shock changed with time?
1998
Adjunctive Therapy for Septic Shock: A Review of Experimental Approaches
1995
Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages.
1993
PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene
2000 StandoutNobel
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
1995
Nosocomial Pneumonia
2002
The L-Arginine-Nitric Oxide Pathway
1993 Standout
The immune response of Drosophila
2003 StandoutNatureNobel
E5 Murine Monoclonal Antiendotoxin Antibody in Gram-Negative Sepsis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2000
MIF as a glucocorticoid-induced modulator of cytokine production
1995 StandoutNature
Antibodies against CD14 protect primates from endotoxin-induced shock.
1996
Origin and physiological roles of inflammation
2008 StandoutNature
Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme
1999
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
1994 StandoutScience
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia
2002
Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation
2000
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Cancer-related inflammation
2008 StandoutNature
The inflammatory reflex
2002 StandoutNature
Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials
2008
E5531, a synthetic non‐toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide
1999
Efficacy of Meropenem as Monotherapy in the Treatment of Ventilator-Associated Pneumonia
2001
The Epidemiology of Sepsis in the United States from 1979 through 2000
2003 Standout
Inhibition of Nitric Oxide Synthase in Experimental Gram-Negative Sepsis
1994
Protection from septic shock by neutralization of macrophage migration inhibitory factor
2000
Staphylococcus aureusInfections
1998 Standout
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
2007
The immunopathogenesis of sepsis
2002 StandoutNature
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
1993 StandoutNature
Pathogenesis and Treatment of the Adult Respiratory Distress Syndrome
1996
HMGB1 as a Late Mediator of Lethal Systemic Inflammation
2001
Ventilator-associated Pneumonia
2002 Standout
Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans
1993
Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta.
1994
Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
2000 StandoutNobel
Role for L-selectin in lipopolysaccharide-induced activation of neutrophils
1996
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
1998 StandoutScienceNobel
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
1999 StandoutScience
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
2014
Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
1999 Standout
Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes
1994
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
1995 StandoutScience
Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis
1995 StandoutScience
Prospective Randomized Comparison of Imipenem-Cilastatin and Piperacillin-Tazobactam in Nosocomial Pneumonia or Peritonitis
1998
Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
1998
ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS
1984 StandoutNobel
Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study
2003
Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells
1991
Characterization of Early Cytokine Responses and an Interleukin (IL)-6–dependent Pathway of Endogenous Glucocorticoid Induction during Murine Cytomegalovirus Infection
1997
An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains
1997
Comparison of Strategies Using Cefpirome and Ceftazidime for Empiric Treatment of Pneumonia in Intensive Care Patients
1998
ACQUIRED IMMUNODEFICIENCY IN AN INFANT: POSSIBLE TRANSMISSION BY MEANS OF BLOOD PRODUCTS
1983
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia
1997
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
1995 StandoutNobel
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Interferon gamma receptor deficient mice are resistant to endotoxic shock.
1994
MICROBIOLOGIC DIAGNOSIS OF VENTILATOR-ASSOCIATED PNEUMONIA
1993
Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways
1997 StandoutScience
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
The Acute Respiratory Distress Syndrome
1996 Standout
Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression
1995
Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo.
1993
Interleukin 10 protects mice from lethal endotoxemia.
1993
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Tumor Cells Deactivate Human Monocytes by Up-Regulating IL-1 Receptor Associated Kinase-M Expression via CD44 and TLR4
2005
The Pathogenesis of Sepsis
1991
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
2012
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
1999
Works of J. D. Baumgartner being referenced
Use of Immunoglobulins in Prevention and Treatment of Infection in Critically III Patients: Review and Critique
1991
Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous Lipopolysaccharides
1991
Septic shock: pathogenesis
1991
Competition between Bactericidal/Permeability-Increasing Protein and Lipopolysaccharide-Binding Protein for Lipopolysaccharide Binding to Monocytes
1993
Pathogenesis and Potential Strategies for Prevention and Treatment of Septic Shock: An Update
1994
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock
1990
Sepsis and septic shock.
1997
IFN-gamma involvement in the severity of gram-negative infections in mice.
1993
Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes
1992
Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.
1990
Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
1993
Purification and characterization of murine lipopolysaccharide-binding protein
1993
Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
1992
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
1994
Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment
1983
Comparative study of imipenem in severe infections
1983
An extreme form of the hyperdynamic syndrome in septic shock
1984
SEVERE CYTOMEGALOVIRUS INFECTION IN MULTIPLY TRANSFUSED, SPLENECTOMISED, TRAUMA PATIENTS
1982